Search

everythinglearnresearchcommunity

for

Search:↓

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

Conditions affecting sex development show that sexual diversity is a natural part of human variation.

5α-Reductase inhibitors can negatively impact sexual function.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Public interest in finasteride's sexual side effects has significantly increased.

Public awareness of finasteride's sexual side effects has increased, suggesting healthcare providers should discuss these risks more thoroughly with patients.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Public interest in finasteride's sexual side effects has significantly increased, highlighting the need for better patient discussions.

Finasteride, a hair loss treatment, may cause long-term sexual dysfunction and depression.

Finasteride, a hair loss drug, can cause long-lasting sexual side effects like low libido and erectile dysfunction.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

Sexual activity can spread T. interdigitale, needing quick antifungal treatment to avoid permanent scarring.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.